Sanjay Gandhi to Drug-Eluting Stents
This is a "connection" page, showing publications Sanjay Gandhi has written about Drug-Eluting Stents.
Connection Strength
0.446
-
Schafer PE, Sacrinty MT, Cohen DJ, Kutcher MA, Gandhi SK, Santos RM, Little WC, Applegate RJ. Cost-effectiveness of drug-eluting stents versus bare metal stents in clinical practice. Circ Cardiovasc Qual Outcomes. 2011 Jul; 4(4):408-15.
Score: 0.101
-
Hayes KR, Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC. Target lesion revascularization after bare-metal or drug-eluting stents: clinical presentations and outcomes. J Invasive Cardiol. 2010 Jun; 22(6):266-70.
Score: 0.094
-
Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC. 3-year comparison of drug-eluting versus bare-metal stents. JACC Cardiovasc Interv. 2009 Mar; 2(3):231-9.
Score: 0.086
-
Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC. Effect of length and diameter of drug-eluting stents versus bare-metal stents on late outcomes. Circ Cardiovasc Interv. 2009 Feb; 2(1):35-42.
Score: 0.086
-
Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Baki TT, Little WC. "Off-label" stent therapy 2-year comparison of drug-eluting versus bare-metal stents. J Am Coll Cardiol. 2008 Feb 12; 51(6):607-14.
Score: 0.080